Abstract:Background: Currently, no satisfactory biomarkers are available to screen for lung cancer. Surface-Enhanced Laser Desorption/ionization Time-of- Flight Mass Spectrometry ProteinChip system (SELDI-TOF-MS) is one of the currently used techniques to identify biomarkers for cancers. The aim of this study is to explore the application of serum SELDI proteomic patterns to distinguish lung cancer patients from healthy individuals.Methods: A total of 208 serum samples, including 158 lung cancer patients and 50 healthy individuals, were randomly divided into a training set (including 11 sera from patients with stages I/II lung cancer, 63 from patients with stages III/IV lung cancer and 20 from healthy controls) and a blinded test set (including 43 sera from patients with stages I/II lung cancer, 41 from patients with stages III/IV lung cancer and 30 from healthy controls). All samples were analyzed by SELDI technology. The spectra were generated on weak cation exchange (WCX2) chips, and protein peaks clustering and classification analyses were made using Ciphergen Biomarker Wizard and Biomarker Pattern software, respectively. We additionally determined Cyfra21-1 and NSE in the 208 serum samples included in this study using an electrochemiluminescent immunoassay.Results: Five protein peaks at 11493, 6429, 8245, 5335 and 2538 Da were automatically chosen as a biomarker pattern in the training set. When the SELDI marker pattern was tested with the blinded test set, it yielded a sensitivity of 86.9%, a specificity of 80.0% and a positive predictive value of 92.4%. The sensitivities provided by Cyfra21-1 and NSE used individually or in combination were significantly lower than that of the SELDI marker pattern (P < 0.005 or 0.05, respectively). Based on the results of the test set, we found that the SELDI marker pattern showed a sensitivity of 91.4% in the detection of non-small cell lung cancers (NSCLC), which was significantly higher than that in the detection of small cell lung cancers (P < 0.05); The pattern also had a sensitivity of 79.1% in the detection of lung cancers in stages I/II.Conclusion: These results suggest that serum SELDI protein profiling can distinguish lung cancer patients, especially NSCLC patients, from normal subjects with relatively high sensitivity and specificity, and the SELDI- TOF- MS is a potential tool for the screening of lung cancer.

Discovery of Biomarkers in the Serum from Colorectal Cancer by Use of SELDI-TOF Mass Spectrometry

[Application of Saliva Protein Fingerprints in the Diagnosis of Oral Squamous Cell Cancer by Surface Enhanced Laser Desorption Ionization Time of Flight Mass].

A Serum Proteomic Pattern for the Detection of Colorectal Adenocarcinoma Using Surface Enhanced Laser Desorption and Ionization Mass Spectrometry

Identification of Colorectal Cancer Using Proteomic Patterns in Serum

Clinical Significance of Biomarkers from Serum in Liver Cancer by SELDI-TOF Mass Spectrometry

Diagnosis of pancreatic adenocarcinoma using protein chip technology.

[Classification and Diagnostic Prediction of Colorectal Cancer Using Protein Profiling of Serum and Bioinformatics].

Establishment of Serum Protein Pattern for Screening Colorectal Cancer Using SELDI-TOF-MS.

Study of distinct serum proteomics for the biomarkers discovery in colorectal cancer.

Establishing Diagnostic Model of Serum Protein Fingerprinting Patterns for Henatic Metastasis of Coloretal Carcinoma and Its Clinical Application

Artificial Neural Networks Analysis Of Surface-Enhanced Laser Desorption/Ionization Mass Spectra Of Serum Protein Pattern Distinguishes Colorectal Cancer From Healthy Population

[Application of Serum Protein Pattern Model in Diagnosis of Colorectal Cancer].

Protein Fingerprint of Colorectal Cancer, Adenomatous Polyps, and Normal Mucosa Using ProteinChip Analysis on Laser Capture Microdissected Cells.

Significance of serum protein fingerprinting for differential diagnosis of colorectal cancer

Differential Expression of Proteomics Models of Colorectal Cancer, Colorectal Benign Disease and Healthy Controls

Biomarker Discovery of Colorectal Mucinous Adenocarcinoma by Fingerprint and Support Vector Machine

Serum Proteomic Patterns for Gastric Lesions As Revealed by SELDI Mass Spectrometry.

An Integrated Approach to the Detection of Colorectal Cancer Utilizing Proteomics and Bioinformatics

Serum Peptidome Patterns of Colorectal Cancer Based on Magnetic Bead Separation and MALDI-TOF Mass Spectrometry Analysis

Application of Serum Seldi Proteomic Patterns in Diagnosis of Lung Cancer

Establishing a model of classification tree for stage I colorectal cancer using surface-enhanced laser desorption ionization time-of-flight mass spectrometry